Document and Entity Information
Document and Entity Information | Dec. 22, 2023 |
Document And Entity Information [Line Items] | |
Document Type | 8-K |
Document Period End Date | Dec. 22, 2023 |
Entity Registrant Name | QUINCE THERAPEUTICS, INC. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-38890 |
Entity Tax Identification Number | 90-1024039 |
Entity Address Address Line 1 | 611 Gateway Boulevard |
Entity Address Address Line 2 | Suite 273 |
Entity Address City Or Town | South San Francisco |
Entity Address State Or Province | CA |
Entity Address Postal Zip Code | 94080 |
City Area Code | 415 |
Local Phone Number | 910-5717 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | false |
Amendment Flag | false |
Entity Central Index Key | 0001662774 |
Former Address [Member] | |
Document And Entity Information [Line Items] | |
Entity Address Address Line 1 | 601 Gateway Boulevard |
Entity Address Address Line 2 | Suite 1250 |
Entity Address City Or Town | South San Francisco |
Entity Address State Or Province | CA |
Entity Address Postal Zip Code | 94080 |
Common Stock, par value $0.001 per share [Member] | |
Document And Entity Information [Line Items] | |
Security 12b Title | Common Stock, par value $0.001 per share |
Trading Symbol | QNCX |
Security Exchange Name | NASDAQ |
Series A Junior Participating Preferred Purchase Rights [Member] | |
Document And Entity Information [Line Items] | |
Security 12b Title | Series A Junior Participating Preferred Purchase Rights |
Security Exchange Name | NASDAQ |
No Trading Symbol Flag | true |